Effects of leucine-rich protein supplements in older adults with sarcopenia: A systematic review and meta-analysis of randomized controlled trials

Arch Gerontol Geriatr. 2022 Sep-Oct:102:104758. doi: 10.1016/j.archger.2022.104758. Epub 2022 Jun 24.

Abstract

Objectives: This study examined whether leucine-rich protein supplements improve muscle strength, mass, and performance in sarcopenic older adults.

Methods: We searched PubMed-Medline, Embase, and Cochrane Library databases for randomized controlled trials comparing leucine-rich protein supplements with a control intervention in sarcopenic older adults. A pairwise meta-analysis using a fixed-effects model was performed. The primary outcome of interest was muscle strength regardless of the measures used. Effect sizes were computed as standardized mean differences (SMDs) with 95% confidence intervals (CIs).

Results: Six randomized controlled trials including a total of 699 participants were retrieved. Leucine-rich protein supplements improved participants' overall muscle strength, mass, and performance compared to the control group (SMD = 0.939; 95% CI, 0.440-1.438; P < 0.001). As the primary outcome, muscle strength improved significantly in the leucine group (SMD = 0.794; 95% CI, 0.104-1.485; P = 0.024).

Conclusion: Leucine-rich protein supplements improve muscle strength in sarcopenic older adults. They may be suggested in nutritional treatment of sarcopenia.

Keywords: Aging; Leucine; Meta-analysis; Nutritional support; Sarcopenia.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Dietary Supplements
  • Humans
  • Leucine / pharmacology
  • Leucine / therapeutic use
  • Muscle Strength / physiology
  • Muscle, Skeletal / physiology
  • Randomized Controlled Trials as Topic
  • Sarcopenia* / drug therapy

Substances

  • Leucine